Sen. Grassley says Mylan's $465 million Epi-Pen settlement 'shortchanges' taxpayers
August 17, 2017 at 17:48 PM EDT
The settlement came after an unusual lawsuit by Sanofi, a competitor to Mylan, which alleged anti-competitive tactics.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|